Isoform switching in various genes (such as PKM, CXCR3 and FGR2 [34–36]) during cancer development has been described in several cancer types including prostate cancer [37–40], and likewise tumour-specific isoforms of known genes have been identified previously [41]. This evidence concerns the gene PKM and prostate cancer.